INTERNATIONAL PATENT: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, CERES BRAIN THERAPEUTICS FILES APPLICATION FOR "DNA METHYLATION AS A BIOMARKER FOR CEREBRAL CREATINE DEFICIENCY SYNDROMES"

GENEVA, July 1 -- COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (25 rue LeblancBat Le Ponant75015 PARIS), CERES BRAIN THERAPEUTICS (37 Boulevard Berthier75017 PARIS) filed a patent application (PCT/EP2024/087083) for "DNA METHYLATION AS A BIOMARKER FOR CEREBRAL CREATINE DEFICIENCY SYNDROMES" on Dec 18, 2024. With publication no. WO/2025/132568, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MABONDZO, Aloise (CEA Saclay-Bat 13691190 GIF-SUR-YVETTE), DISDIER, Clemence (CEA Saclay-Bat 13691190 GIF-SUR-YVETT...